Literature DB >> 17960765

Early loss of dopaminergic terminals in striosomes after MDMA administration to mice.

Noelia Granado1, Isabel Escobedo, Esther O'Shea, Isabel Colado, Rosario Moratalla.   

Abstract

The amphetamine analogue 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") is a popular drug of abuse which causes different neurotoxic effects in the mouse compared with the rat. In mice, MDMA produces damage to striatal dopamine terminals, having little long-term effects on serotonin (5-HT) containing neurons. A relevant feature of the striatum is its striosome/matrix compartmental organization; defined by different connexions, and functions. In this study we examined the long-term effect induced by MDMA on tyrosine hydroxylase (TH) and dopamine transporter (DAT) immunoreactivity in the striosomes and matrix compartments of mouse striatum. Mice given MDMA showed significant reductions in TH and DAT immunostaining in striatum compared with control animals. Interestingly, this effect was considerably more pronounced in striosomes than in the matrix. These data provide the first evidence that striosomes and matrix compartments of the mouse striatum have differential vulnerability to MDMA and that the long-term neurotoxicity induced by MDMA in mice is primarily associated with a loss of striosomal dopamine fibres. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17960765     DOI: 10.1002/syn.20466

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  26 in total

1.  Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L-DOPA in a mouse model of Parkinson's disease.

Authors:  Ettel Keifman; Irene Ruiz-DeDiego; Diego Esteban Pafundo; Rodrigo Manuel Paz; Oscar Solís; Mario Gustavo Murer; Rosario Moratalla
Journal:  Br J Pharmacol       Date:  2019-05-21       Impact factor: 8.739

2.  Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice.

Authors:  Daniel W Curry; Matthew B Young; Andrew N Tran; Georges E Daoud; Leonard L Howell
Journal:  Neuropharmacology       Date:  2017-10-06       Impact factor: 5.250

3.  The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI).

Authors:  Shahaf Edut; Vardit Rubovitch; Shaul Schreiber; Chaim G Pick
Journal:  Psychopharmacology (Berl)       Date:  2010-12-01       Impact factor: 4.530

4.  Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy.

Authors:  Jill R Crittenden; Ippolita Cantuti-Castelvetri; Esen Saka; Christine E Keller-McGandy; Ledia F Hernandez; Lauren R Kett; Anne B Young; David G Standaert; Ann M Graybiel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

5.  Methamphetamine-induced toxicity in indusium griseum of mice is associated with astro- and microgliosis.

Authors:  Ana Carmena; Noelia Granado; Sara Ares-Santos; Samuel Alberquilla; Yousef Tizabi; Rosario Moratalla
Journal:  Neurotox Res       Date:  2014-12-10       Impact factor: 3.911

6.  Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice.

Authors:  I Peraile; E Torres; A Mayado; M Izco; A Lopez-Jimenez; J A Lopez-Moreno; M I Colado; E O'Shea
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

7.  A spontaneous deletion of α-synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: effects on alcohol consumption.

Authors:  Alejandro López-Jiménez; Nicole A R Walter; Elena Giné; Ángel Santos; Victor Echeverry-Alzate; Kora-Mareen Bühler; Pedro Olmos; Stéphanie Giezendanner; Rosario Moratalla; Lluis Montoliu; Kari J Buck; Jose Antonio López-Moreno
Journal:  Synapse       Date:  2013-03-20       Impact factor: 2.562

8.  Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders.

Authors:  Ines Peraile; Noelia Granado; Elisa Torres; M Dolores Gutiérrez-López; Rosario Moratalla; M Isabel Colado; Esther O'Shea
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

9.  Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum.

Authors:  María Izco; Maria Dolores Gutierrez-Lopez; Ivanny Marchant; Esther O'Shea; Maria Isabel Colado
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

10.  Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

Authors:  Noelia Granado; Sara Ares-Santos; Esther O'Shea; Carlos Vicario-Abejón; M Isabel Colado; Rosario Moratalla
Journal:  Neurotox Res       Date:  2009-09-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.